Literature DB >> 9671697

A model for MRI contrast enhancement using T1 agents.

E T Ahrens1, U Rothbächer, R E Jacobs, S E Fraser.   

Abstract

Contrast in MRI relies on differences in the local environment of water and is often enhanced by using contrast agents. We present a simple model for evaluating the minimal contrast agent concentration required to produce "satisfactory" contrast enhancement in magnetic resonance images. Previous strategies have been based largely on empirical results for specific systems. The present tissue contrast model (TCM) can be applied to "conventional," targeted, or biochemically responsive agents. The model results are formulated so that only a small number of parameters are required to analyze a given scenario. The TCM is a particularly useful tool in the development of new classes of magnetic resonance contrast media. These agents will have the ability to target specific cells or tissue, and perhaps be able to report on their physiological status. As an example of the applicability of the TCM, we test it against in vivo magnetic resonance microscopy results in frog embryos that have focal cell populations labeled with contrast agent by using calibrated single-cell microinjection techniques.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9671697      PMCID: PMC21095          DOI: 10.1073/pnas.95.15.8443

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Rationale and applications for macromolecular Gd-based contrast agents.

Authors:  R C Brasch
Journal:  Magn Reson Med       Date:  1991-12       Impact factor: 4.668

2.  Targeted relaxation enhancement agents for MRI.

Authors:  R B Lauffer
Journal:  Magn Reson Med       Date:  1991-12       Impact factor: 4.668

3.  Receptor-targeted co-transport of DNA and magnetic resonance contrast agents.

Authors:  J F Kayyem; R M Kumar; S E Fraser; T J Meade
Journal:  Chem Biol       Date:  1995-09

4.  Optimizing tissue contrast in magnetic resonance imaging.

Authors:  R E Hendrick; T R Nelson; W R Hendee
Journal:  Magn Reson Imaging       Date:  1984       Impact factor: 2.546

5.  The dependence of nuclear magnetic resonance (NMR) image contrast on intrinsic and pulse sequence timing parameters.

Authors:  F W Wehrli; J R MacFall; G H Glover; N Grigsby; V Haughton; J Johanson
Journal:  Magn Reson Imaging       Date:  1984       Impact factor: 2.546

6.  Selection of pulse sequences producing maximum tissue contrast in magnetic resonance imaging.

Authors:  T R Nelson; R E Hendrick; W R Hendee
Journal:  Magn Reson Imaging       Date:  1984       Impact factor: 2.546

7.  Pulse sequence optimization for MR imaging using a paramagnetic hepatobiliary contrast agent.

Authors:  W L Greif; R B Buxton; R B Lauffer; S Saini; D D Stark; V J Wedeen; B R Rosen; T J Brady
Journal:  Radiology       Date:  1985-11       Impact factor: 11.105

8.  Signal, noise, and contrast in nuclear magnetic resonance (NMR) imaging.

Authors:  W A Edelstein; P A Bottomley; H R Hart; L S Smith
Journal:  J Comput Assist Tomogr       Date:  1983-06       Impact factor: 1.826

9.  Magnetic resonance imaging using gadolinium labeled monoclonal antibody.

Authors:  E C Unger; W G Totty; D M Neufeld; F L Otsuka; W A Murphy; M S Welch; J M Connett; G W Philpott
Journal:  Invest Radiol       Date:  1985-10       Impact factor: 6.016

10.  A new lipophilic gadolinium chelate as a tissue-specific contrast medium for MRI.

Authors:  H J Weinmann; G Schuhmann-Giampieri; H Schmitt-Willich; H Vogler; T Frenzel; H Gries
Journal:  Magn Reson Med       Date:  1991-12       Impact factor: 4.668

View more
  18 in total

1.  Toward the Design of MR Agents for Imaging β-Cell Function.

Authors:  Mark Woods; Shanrong Zhang; A Dean Sherry
Journal:  Curr Med Chem Immunol Endocr Metab Agents       Date:  2004-12

2.  The detection limit of a Gd3+-based T1 agent is substantially reduced when targeted to a protein microdomain.

Authors:  Kenjiro Hanaoka; Angelo Josue M Lubag; Aminta Castillo-Muzquiz; Thomas Kodadek; A Dean Sherry
Journal:  Magn Reson Imaging       Date:  2008-01-30       Impact factor: 2.546

3.  Nanoparticle pharmacokinetic profiling in vivo using magnetic resonance imaging.

Authors:  Anne M Neubauer; Hoon Sim; Patrick M Winter; Shelton D Caruthers; Todd A Williams; J David Robertson; David Sept; Gregory M Lanza; Samuel A Wickline
Journal:  Magn Reson Med       Date:  2008-12       Impact factor: 4.668

4.  Investigation of a calcium-responsive contrast agent in cellular model systems: feasibility for use as a smart molecular probe in functional MRI.

Authors:  Goran Angelovski; Sven Gottschalk; Milena Milošević; Jörn Engelmann; Gisela E Hagberg; Pascal Kadjane; Pavle Andjus; Nikos K Logothetis
Journal:  ACS Chem Neurosci       Date:  2014-04-08       Impact factor: 4.418

Review 5.  A review of responsive MRI contrast agents: 2005-2014.

Authors:  Dina V Hingorani; Adam S Bernstein; Mark D Pagel
Journal:  Contrast Media Mol Imaging       Date:  2014-10-29       Impact factor: 3.161

6.  Core/shell quantum dots with high relaxivity and photoluminescence for multimodality imaging.

Authors:  Shizhong Wang; Benjamin R Jarrett; Susan M Kauzlarich; Angelique Y Louie
Journal:  J Am Chem Soc       Date:  2007-03-15       Impact factor: 15.419

7.  (89)Zr-labeled paramagnetic octreotide-liposomes for PET-MR imaging of cancer.

Authors:  Diane S Abou; Daniel L J Thorek; Nicholas N Ramos; Martijn W H Pinkse; Hubert T Wolterbeek; Sean D Carlin; Bradley J Beattie; Jason S Lewis
Journal:  Pharm Res       Date:  2012-12-07       Impact factor: 4.200

8.  Development of contrast agents targeted to macrophage scavenger receptors for MRI of vascular inflammation.

Authors:  Björn Gustafsson; Susan Youens; Angelique Y Louie
Journal:  Bioconjug Chem       Date:  2006 Mar-Apr       Impact factor: 4.774

Review 9.  Detecting enzyme activities with exogenous MRI contrast agents.

Authors:  Dina V Hingorani; Byunghee Yoo; Adam S Bernstein; Mark D Pagel
Journal:  Chemistry       Date:  2014-07-02       Impact factor: 5.236

10.  A biomarker-responsive T2ex MRI contrast agent.

Authors:  Iman Daryaei; Edward A Randtke; Mark D Pagel
Journal:  Magn Reson Med       Date:  2016-04-19       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.